What can we do?
We will continue to monitor and track the number of people diagnosed with autism over time to determine if the number is rising, dropping, or staying the same. We can also compare the number of children with autism in different areas of the country and among different groups of people. This information can help us look for causes of autism and can help communities plan for services.
Through our Study to Explore Early Development (SEED), we will:
o Examine the physical and behavioral characteristics of children with autism, children with other developmental disabilities, and children without a developmental delay or disability. o Compare health conditions among children with and without autism. o Investigate factors associated with a child's risk for developing autism.
In 2011, we began analyzing the initial results of SEED, focusing on describing the children in terms of specific behaviors, developmental progress, medical issues, genetic and pregnancy factors, and demographics (age, race/ethnicity, gender, place of birth/residence). We also initiated the second phase of SEED and completed enrollment of families for the largest study in the U. S. to help identify factors that may put children at risk for autism. This effort will increase the number of families enrolled in SEED, allowing us to get better estimates of risk.
Most children who have autism are not diagnosed until after they reach age 4, even though many children can be identified before age 2. CDC supports recommendations that all children be screened by age 2, because early screening and diagnosis improve access to services during a child's most critical developmental period. 
Did you know?
Study to Explore Early Development (SEED) enrolled more than 3,700 children and their families in the largest study in the U.S. to help identify what puts children at risk for autism. SEED looks at autism risk factors across the population; a unique contribution to the Interagency Autism Coordinating Committee (IACC) Strategic Plan for Autism Research.
NCBDDD's "Learn the Signs. Act Early." program is working to improve awareness of developmental milestones and the importance of tracking them among parents, health care providers and early educators. We are currently funding four state demonstration grants in Utah, Washington, Missouri, and Alaska to help determine effective methods for reaching parents. One grantee in St. Louis, Missouri, has implemented "Learn the Signs. Act Early." messages and materials in 12 Women, Infants and Children (WIC) clinics. Milestone checklists are completed for every child who receives WIC benefits and parents are referred to health care providers as appropriate.
We continue to track the occurrence of autism in younger children. By tracking autism among 4-yearold children, we can improve efforts at identifying the condition earlier.
We will continue working with partners and stakeholders to develop ways to close the gap between when parents first have a concern about their child and when they receive a diagnosis. The earlier we can identify that a child has autism and the earlier we can get them into services, the more that child can benefit. However, parents do not need to wait for a diagnosis to get services and support.
Accomplishments
NCBDDD and the Health Resources and Services Administration (HRSA) published a study showing that developmental disabilities are common: about 1 in 6 children in the U.S. had a developmental disability in [2006] [2007] [2008] . This tracking data also show that parent-reported developmental disabilities have increased 17.1% from 1997 to 2008. This study underscores the increasing need for health, education and social services, and more specialized health services for people with developmental disabilities.
NCBDDD developed a mathematical model to estimate how changes in pregnancy and birth factors might have contributed to the subsequent increase in autism. The data showed that each pregnancy factor examined likely accounted for less than 1% of the total increase (pregnancy factors included preterm and very preterm delivery, low and very low birth weight, multiple birth, cesarean delivery, breech presentation, and use of in vitro fertilization or other assisted reproductive technologies).
To increase awareness of developmental milestones, NCBDDD's "Learn the Signs. Act Early." program has created a new children's book, Amazing Me: It's Busy Being 3! The story of an amazing 3-year old kangaroo holds the child's attention and inspires an interest in books and reading while educating the parent-reader about different milestones that are important signs of a child's development. Amazing Me also encourages the parent-reader to look for milestones in their own child, provides parents a tool to track their child's development, and encourages parents to talk with their child's doctor about their child's development. Books will be distributed free to low-income parents of 3-year-olds through the Reach Out and Read pediatric network and in partnership with the American Academy of Pediatrics/Bright Futures. The book is also available on CDC's website.
NCBDDD's data on the burden of autism and descriptive characteristics of children with the condition are used to inform the Interagency Autism Coordinating Committee (IACC) Strategic Plan for Autism Research. Working in collaboration with the IACC, our autism activities complement the goals and objectives of the plan.
NCBDDD conducted a workshop in partnership with Autism Speaks to understand identification issues and risk factors influencing increases in autism. The workshop brought together scientists and stakeholders from the autism community to increase knowledge about autism prevalence, to learn from other conditions, and to share ideas on how to move forward to better understand autism trends. An executive summary and the complete workshop summary are available for download on our website.
NCBDDD worked with partners from other federal agencies to establish, for the first time, a Healthy People 2020 goal focused on autism screening, diagnosis, and enrollment in services. These measurable goals are important because the Autism and Developmental Disabilities Monitoring (ADDM) data show that caregivers or service providers typically have concerns about a child's development before they are 2, but most children are still being diagnosed much later, after 4. 
Did you know?

Early intervention (before school age) can have a significant impact on a child's ability to learn new skills as well as reduce the need for costly interventions over time. In the United States, about 1 in 110 children has autism and about 1 in 6 children aged 3-17 has a developmental disability.
'Learn the Signs. Act Early'. Ambassadors, June 23, 2011.
The Interagency Autism Coordinating Committee (IACC) is a Federal advisory committee that coordinates all efforts within the Department of Health and Human Services (HHS) related to autism. Through its inclusion of both Federal and public members, the IACC helps to ensure that a wide range of ideas and perspectives are represented and discussed in a public forum. Each year, the IACC develops a strategic plan for autism research that takes into account all that we've learned about autism in the previous years and keeps the federal response to autism focused and informed.
Looking to the future
Our ADDM Network will continue to help us learn more about autism, including understanding which children are more likely to have autism diagnosis and at what age that diagnosis is likely to be made.
NCBDDD will continue collaborations with HRSA to implement and evaluate the "Learn the Signs. Act Early." campaign through four state demonstration grants (Utah, Washington, Missouri, and Alaska). Results on the feasibility and impact of these efforts will be available in early 2013.
In 2012, through SEED, NCBDDD will investigate maternal medication use, infections, and lifestyle factors and whether they interact with some children's genes to put them at greater risk for autism.
With the current infrastructure in place, we are well positioned to expand our work in the area of cerebral palsy by:
o Increasing the tracking sample size to allow better examination of the characteristics of children with cerebral palsy, including socioeconomic factors and specific subtypes. o Conducting population-based research to identify additional strategies to prevent cerebral palsy and to detect the relationships between risk factors and cerebral palsy. NCBDDD will continue partnerships with National Institutes of Health and Autism Speaks to investigate autism in Somali children compared to other populations located in Minneapolis. Results could provide a framework for future studies on the risk factors and causes of autism and may also provide data that can be used for advocacy and service planning.
NCBDDD began working through a public/private partnership with Autism Speaks to evaluate the use of direct screening and assessment to enhance the completeness of autism estimates. Through this partnership, Autism Speaks is providing supplemental funding to add complementary screening and assessment to one of the ADDM sites.
